Commodore Capital »

Galecto shares owned by Commodore Capital

Quarter-by-quarter ownership of Galecto (DMRA) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galecto by Commodore Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $50M 1.9M 25.90

More positions owned by Commodore Capital

Relay Therapeutics (RLAY)
Alkermes SHS (ALKS)
Enliven Therapeutics (ELVN)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Tyra Biosciences (TYRA)
Celldex Therapeutics Com New (CLDX)
Nuvalent Inc-a (NUVL)
Amylyx Pharmaceuticals (AMLX)
Kymera Therapeutics (KYMR)
Alto Neuroscience Com Shs (ANRO)
Pharvaris N V (PHVS)
Erasca (ERAS)
Damora Therapeutics Com New (DMRA)
Xenon Pharmaceuticals (XENE)

View all positions for Commodore Capital

Top funds holding Galecto

Fairmount Funds Management
VR Adviser
RA Capital Management
Henderson Group
Viking Global Investors
Remedium Capital Partners
Commodore Capital
Cormorant Asset Management
Balyasny Asset Management
AH Capital Management
Perceptive Advisors
Point72 Asset Management
Braidwell
Vestal Point Capital
Blackstone Group

View all funds holding Galecto